Analyst Ratings for Arcturus Therapeutics (ARCT)
ARCT Rating Summary
ARCT Price Target Summary
- Highest: $68.00 (Laidlaw)
- Lowest: $8.00 (Citi)
- Average: $24.44
* Over Last 12-Mos
Overall Rating:
NEUTRAL
Rating Trend:
Avg. $ Target:
$24.44 (+224.6%)
* Over Last 12-Mos
Rating Score: 6 / 10
Percentile Rank: 63%
Avg. $ Target:
$24.44 (+224.6%)
* Over Last 12-Mos
Rating Score: 6 / 10
Percentile Rank: 63%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 3/18/2026 | B.Riley | Mayank Mamtani | New Coverage | Buy (N/A) |
22.00 (N/A) |
6.63 (7.53) |
13.57% | Details |
| 1/23/2026 | Roth/MKM | ADAM | New Coverage | Buy (N/A) |
20.00 (N/A) |
7.27 (7.53) |
3.58% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
